Table 3.
Pathologic results
| Operative Variables | n | (%) or [IQR] |
|---|---|---|
| [y] pTNM stage | ||
| 0 | 6 | (20) |
| I | 7 | (23.3) |
| II | 4 | (13.3) |
| III | 10 | (33.3) |
| IV | 3 | (10) |
| Number of examined lymph nodes a | 20 | [14-25] |
| Status of CRM+ | ||
| Negative | 30 | (100) |
| CRM distance mm b | 11 | [5-20] |
| TME Integrity | ||
| Complete | 25 | (83.3) |
| Nearly Complete c | 5 | (16.7) |
| Incomplete d | 0 | (0) |
a
Median values with interquartile range [IQR]
b
Quantitative distance available for 26 patients (not applicable for patients with pathologic complete response)
c
Presence of ,5-mm areas of disruption of the mesorectal envelope with no loss of fat.
d
A >5-mm defect with loss of fat or with coning.